Takenari Gotanda
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
-
- Bladder and Urothelial Cancer Treatments 2
-
- T-cell and Retrovirus Studies 1
- Co-authors
- Masayuki NakagawaHideki EnokidaKenryu NishiyamaMisako HaraguchiTatsuhiko FurukawaTokushi TachiwadaTomoyuki SumizawaNaohiko Seki
- Journals
- Oncology Reports (3 papers)Biochemical and Biophysical Research Communications (2 papers)Cancer Research (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Takenari Gotanda
16 papers receiving 579 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 212
- Molecular Biology 404
- Oncology 142
- Urology 23
- Genetics 22
Countries citing papers authored by Takenari Gotanda
This map shows the geographic impact of Takenari Gotanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takenari Gotanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takenari Gotanda more than expected).
Fields of papers citing papers by Takenari Gotanda
This network shows the impact of papers produced by Takenari Gotanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takenari Gotanda. The network helps show where Takenari Gotanda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takenari Gotanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 1 | |
| 2 | 2011 | 51 | |
| 3 | 2011 | 117 | |
| 4 | 2007 | 7 | |
| 5 | 2006 | 7 | |
| 6 | 2006 | 28 | |
| 7 | 2006 | 36 | |
| 8 | 2006 | 28 | |
| 9 | 2006 | 12 | |
| 10 | 2006 | 48 | |
| 11 | 2005 | 74 | |
| 12 | 2004 | 24 | |
| 13 | 2004 | 53 | |
| 14 | 2002 | 30 | |
| 15 | Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. | 2002 | 45 |
| 16 | 2001 | 20 |
About Takenari Gotanda
Takenari Gotanda is a scholar working on Cancer Research, Transplantation and Oncology, having authored 16 papers that have together received 581 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Treatment and Pharmacology (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Cancer Research (212 citations), Molecular Biology (404 citations) and Oncology (142 citations). Takenari Gotanda has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Masayuki Nakagawa, Hideki Enokida, Kenryu Nishiyama, Misako Haraguchi, Tatsuhiko Furukawa, Tokushi Tachiwada, Tomoyuki Sumizawa, Naohiko Seki, Kazumori Kawakami and Hiroyuki Kubo. Their work appears in journals such as Oncology Reports, Biochemical and Biophysical Research Communications, Cancer Research, Cancer Letters and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.